Edwards wins $74 million judgment in patent war with Medtronic's CoreValve
April 2, 2010 by MassDevice staff
A federal jury in Delaware, ruling that Medtronic Inc. subsidiary CoreValve willfully infringes an Edwards Lifesciences Inc. patent, awards $74 million in damages and opens the door for Edwards to seek triple that amount.
Edwards Lifesciences Inc. (NYSE:EW) won a major round in its patent war with Medtronic Inc. (NYSE:MDT) subsidiary CoreValve when a Delaware federal jury ruled that CoreValve willfully infringes an Edwards patent.
Similar entries
- Show full page
- Login to post comments
-
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
NEWS
MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
St. Jude Medical gains on Goldman upgrade | Wall Street Beat
St. Jude Medical's shares get a 2% lift from an upgrade by a Goldman Sachs analyst.
SEC closed probe of Zoll's Middle East sales just ahead of $2.3B Asahi merger
Just weeks before a $2.3 billion acquisition by Asahi Kasei closed, the Securities & Exchange...
Boston Scientific's Synergy bioabsorbable stent stands up to Promus Element
Boston Scientific's Synergy bioabsorbable drug-eluting stent proves just as good as its leading and...
